首都医科大学学报 ›› 2025, Vol. 46 ›› Issue (4): 632-636.doi: 10.3969/j.issn.1006-7795.2025.04.008

• 更年期妇科内分泌与生育力保护 • 上一篇    下一篇

来曲唑联合资癸女贞胶囊对多囊卵巢综合征子宫内膜薄性不孕患者的疗效观察

马郡1,阮祥燕1,2*,许仲婷1,赵越1,王月姣1,  Alfred O.Mueck1,2   

  1. 1.首都医科大学附属北京妇产医院/北京妇幼保健院内分泌科,北京 100026;2.德国图宾根大学妇产医院妇女健康部与妇女健康研究中心,图宾根 D-72076
  • 收稿日期:2025-01-17 出版日期:2025-08-21 发布日期:2025-08-29
  • 通讯作者: 阮祥燕 E-mail:ruanxiangyan@ ccmu.edu.cn
  • 基金资助:
    妇幼健康研究会中医药治疗不孕不育研究项目(2018AMCHS011)。

Clinical efficacy of letrozole combined with Zi Gui Nv Zhen Capsules in patients with PCOS complicated by thin endometrium-induced infertility

Ma Jun1,Ruan Xiangyan1,2*, Xu Zhongting1 , Zhao Yue1 , Wang Yuejiao1, Alfred O.Mueck1,2   

  1. 1.Department of Gynecological Endocrinology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University. Beijing Maternal and Child Health Care Hospital, Beijing 100026, China;2.Department of Women's Health, Research Centre for Women's Health and University Women's Hospital of Tuebingen, University Hospitals of Tuebingen, Tuebingen D-72076, Germany
  • Received:2025-01-17 Online:2025-08-21 Published:2025-08-29
  • Supported by:
    This study was supported by Association for Maternal and Child Health Studies(2018AMCHS011).

摘要: 目的  探讨来曲唑联合资癸女贞胶囊对多囊卵巢综合征(polycystic ovary syndrome ,PCOS)子宫内膜薄性不孕患者的疗效。方法  招募符合子宫内膜薄性不孕诊断(子宫内膜厚度<0.8 cm,且未避孕1年未孕)的PCOS患者140例,采用数字表法随机分配到对照组和试验组,治疗3个月经周期。对照组患者于月经第3天给予来曲唑2.5 mg/d,月经第8~10天给予戊酸雌二醇片2 mg/d,地屈孕酮序贯10 mg/d。试验组在对照组治疗的基础上给予资癸女贞胶囊治疗。在3周期的治疗期间,观察排卵当日子宫内膜厚度(endometrial thickness,EMT)、排卵率及累计妊娠率。结果  试验组3个月经周期的排卵日子宫内膜厚度均显著高于对照组[(0.86±0.23) cm vs (0.71±0.15) cm;(0.83±0.26) cm vs (0.68±0.19) cm;(0.87±0.26) cm vs (0.71±0.11) cm],试验组累计妊娠率显著高于对照组(44.3% vs 25.7%)。结论  在基础治疗基础上,联合资癸女贞胶囊可增加PCOS子宫内膜薄性患者的子宫内膜厚度,提高PCOS患者的妊娠率。

关键词: 资癸女贞胶囊, 来曲唑, 多囊卵巢综合征, 子宫内膜薄, 不孕, 妊娠率

Abstract: Objective  To investigate the curative effect of letrozole combined with Zi Gui Nv Zhen Capsules on patients with polycystic ovary syndrome (PCOS) complicated by thin endometrial infertility. Methods  140 patients with PCOS who met the diagnosis of endometrial thin infertility (endometrial thickness<0.8 cm and no pregnancy for 1 year without contraception) were recruited and randomly assigned to the control group and the experimental group for 3 cycles of treatment. The control group was given letrozole 2.5 mg/d on the 3rd day of menstruation, estradiol valerate 2 mg/d on the 8-10th day of menstruation, and dydrogesterone 10 mg/d in sequence. The experimental group was treated with Zi Gui Nv Zhen Capsules on the basis of the control group. During 3 cycles of treatment, endometrial thickness (EMT), ovulation rate and cumulative pregnancy rate on the day of ovulation were examined.Results  The EMT of the experiment group was significantly higher than that of the control group on the ovulation day of three cycles [(0.86±0.23) cm vs (0.71±0.15) cm;(0.83±0.26) cm vs (0.68±0.19)cm; (0.87±0.26) cm vs (0.71± 0.11) cm], the cumulative pregnancy rate of experimental group was significantly higher than that of control group (44.3% vs 25.7%). There was no significant difference in ovulation rate between the two groups (P>0.05). Conclusion  Our findings demonstrate that the combined use of Zi Gui Nv Zhen Capsule with basic conventional therapy significantly enhances endometrial thickness and improves pregnancy rates in PCOS patients with thin endometrium.

Key words: Zi Gui Nv Zhen Capsules, letrozole, polycystic ovary syndrome (PCOS), thin endometrium, infertility, pregnancy rate

中图分类号: